Tag: ARRDC1-mediated microvesicles
-
Nation & World
A versatile vessel for next-gen therapeutics
The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.
-
Sections
Featured Topics
Featured series Wondering
A series of random questions answered by Harvard experts.
Explore the Gazette